JUDSON JONES: Open Payments
NPI 1720492200 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,952 in 85 payments from 34 companies in 2025. Trend: 2023 $2,230 · 2024 $1,927 · 2025 $1,952
Food & beverage: $1,877Education: $75
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 11 | $237 |
| AstraZeneca Pharmaceuticals LP | 10 | $196 |
| ABBVIE INC. | 4 | $164 |
| Aveo Pharmaceuticals, Inc. | 6 | $117 |
| Janssen Biotech, Inc. | 4 | $104 |
| Daiichi Sankyo Inc. | 4 | $100 |
| Merck Sharp & Dohme LLC | 4 | $90 |
| GENZYME CORPORATION | 4 | $89 |
| SANOFI-AVENTIS U.S. LLC | 1 | $75 |
| Genentech USA, Inc. | 3 | $71 |
Products named: ENHERTU, SARCLISA, EPKINLY, FOTIVDA, Fabhalta, KEYTRUDA, JEMPERLI, KISQALI.
Industry payments across LA — which companies pay providers there.
